Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Are there potential problems with generic substitution of antiepileptic drugs?

3 references·9 citing·23 second hop

FromToDepth

this work references cited by second hop

References

2003Bioequivalence and other unresolved issues in generic drug substitution213 cited
2003The bioequivalence and therapeutic efficacy of generic versus brand-name psychoative drugs154 cited
1990Assessment [RETIRED]40 cited

Cited by

2008Clinical consequences of generic substitution of lamotrigine for patients with epilepsy117 cited
2008Generic substitution in the treatment of epilepsy: Patient and physician perceptions102 cited
2009CLINICAL CONSEQUENCES OF GENERIC SUBSTITUTION OF LAMOTRIGINE FOR PATIENTS WITH EPILEPSY95 cited
2020The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China94 cited
2010Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century After the 1984 Waxman-Hatch Legislation92 cited
2010Switching from Brand‐Name to Generic Psychotropic Medications: A Literature Review84 cited
2015Potential Clinical and Economic Impact of Switching Branded Medications to Generics76 cited
2013Development of the generic drug industry in the US after the Hatch-Waxman Act of 198474 cited
2007Antiepileptic drugs: generic versus branded treatments69 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work